The Scientific Team at Palleon Pharmaceuticals conducts cutting-edge research and development focused on Glyco-Immune Checkpoint inhibitors to combat cancer. This multidisciplinary team, which includes senior scientific advisors and R&D experts, collaborates on preclinical and clinical studies, engages in detailed analytical and formulation development, and contributes to the overall scientific strategy guiding Palleon's innovative treatment solutions.